TGFB1 and metabolic dysfunction-associated steatohepatitis: We first generated cells to mimic NASH in vivo by treating hepatocytes and macrophages with palmitic acid (PA), and treating HSC-T6 cells with TGFβ (Supplementary Fig. 2f–i).